4.6 Review

Bile acids: regulation of synthesis

期刊

JOURNAL OF LIPID RESEARCH
卷 50, 期 10, 页码 1955-1966

出版社

ELSEVIER
DOI: 10.1194/jlr.R900010-JLR200

关键词

cholesterol 7 alpha-hydroylase; nuclear receptors; farnesoid X receptor; fibroblast growth factor 19; cell signaling; lipid metabolism; cholesterol 7 alpha-hydroxylase; drug therapy; cholestasis; liver diseases

资金

  1. National Institutes of Health [DK-44442, DK-58379]
  2. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058379, R56DK044442, R01DK044442, R37DK058379] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Bile acids are physiological detergents that generate bile flow and facilitate intestinal absorption and transport of lipids, nutrients, and vitamins. Bile acids also are signaling molecules and inflammatory agents that rapidly activate nuclear receptors and cell signaling pathways that regulate lipid, glucose, and energy metabolism. The enterohepatic circulation of bile acids exerts important physiological functions not only in feedback inhibition of bile acid synthesis but also in control of whole-body lipid homeostasis. In the liver, bile acids activate a nuclear receptor, farnesoid X receptor (FXR), that induces an atypical nuclear receptor small heterodimer partner, which subsequently inhibits nuclear receptors, liver-related homolog-1, and hepatocyte nuclear factor 4 alpha and results in inhibiting transcription of the critical regulatory gene in bile acid synthesis, cholesterol 7 alpha-hydroxylase (CYP7A1). In the intestine, FXR induces an intestinal hormone, fibroblast growth factor 15 (FGF15; or FGF19 in human), which activates hepatic FGF receptor 4 (FGFR4) signaling to inhibit bile acid synthesis. However, the mechanism by which FXR/FGF19/FGFR4 signaling inhibits CYP7A1 remains unknown. Bile acids are able to induce FGF19 in human hepatocytes, and the FGF19 autocrine pathway may exist in the human livers. Bile acids and bile acid receptors are therapeutic targets for development of drugs for treatment of cholestatic liver diseases, fatty liver diseases, diabetes, obesity, and metabolic syndrome.-Chiang, J. Y. L. Bile acids: regulation of synthesis. J. Lipid Res. 2009. 50: 1955-1966.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据